Marc Lang

This inventor holds 34 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Antiviral Compounds. Top assignees: Ciba-Geigy Corporation, Novartis Ag, Novartis Finance Corporation. Active years: 1986-2013.

USPTO Granted Patents = 34 (Patent Applications = 2)

% Patents Active = 94.1

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 468(Granted Patents)

Location History:

Rixheim, FR (1986 - 1993)
Mulhouse, FR (1987 - 2013)

Company Filing History:

19 out of 6,858

Ciba-Geigy Corporation

Novartis Finance Corporation

where one patent can have more than one assignee

Years Active: 1986-2013

Loading Chart...

Areas of Expertise:

Protein Kinase Inhibitors

Heterobicyclic Carboxamides

Antiviral Ethers

Pyrimidine Derivatives

HIV Protease Inhibitors

Cyclic Hydrazine Compounds

Naphthalene Derivatives

Bicyclic Beta-Lactam

Thia-Aza Compounds

Pyrazole Derivatives

Azahexane Derivatives

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8552002 - Compounds and compositions as protein kinase inhibitors (2013-10-08),

2. 8058276 - Heterobicyclic carboxamides as inhibitors for kinases (2011-11-15),

3. 6933290 - 2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives (2005-08-23),

4. 6451973 - Anilinopeptide derivatives (2002-09-17),

5. 6300519 - Antivirally active heterocyclic azahexane derivatives (2001-10-09),

6. 6251911 - Pyrimidine derivatives and processes for the preparation thereof (2001-06-26),

7. 6225345 - Azahexane derivatives as substrate isosters of retroviral asparate proteases (2001-05-01),

8. 6180636 - Substituted pyrrolopyrimidines and processes for their preparation (2001-01-30),

9. 6166004 - Combinations of HIV protease inhibitors with reverse transcriptase (2000-12-26),

10. 6110946 - Antivirally active heterocyclic azahexane derivatives (2000-08-29),

11. 5981533 - Pyrazole derivatives and processes for the preparation thereof (1999-11-09),

12. 5935976 - Antiviral ethers of aspartate protease substrate isosteres (1999-08-10),

13. 5849911 - Antivirally active heterocyclic azahexane derivatives (1998-12-15),

14. 5807891 - Antiviral ethers of aspartate protease substrate isosteres (1998-09-15),

15. 5753652 - Antiretroviral hydrazine derivatives (1998-05-19),

Title: Marc Lang - Innovative Inventor from Mulhouse

Introduction: Marc Lang is a renowned inventor hailing from Mulhouse, France, known for his groundbreaking contributions to various industries.

Latest Patents: Marc Lang holds several patents in the fields of renewable energy, sustainable technology, and advanced materials, showcasing his commitment to creating a more eco-friendly world.

Career Highlights: With a career spanning over two decades, Marc Lang has worked with leading research institutions and universities to develop cutting-edge solutions for complex challenges. His innovative approach has led to the successful commercialization of several products.

Collaborations: Throughout his career, Marc Lang has collaborated with top companies, banks, and universities to bring his inventions to life. His ability to work across disciplines and sectors has resulted in impactful innovations with real-world applications.

Conclusion: Marc Lang's passion for innovation and his dedication to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire future generations of inventors and researchers.